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Abstract
Real-time (RT)-PCR increases diagnostic yield for bacterial meningitis and is ideal for incorporation into routine surveillance
in a developing country. We validated a multiplex RT-PCR assay for Streptococcus pneumoniae, Neisseria meningitidis, and
Haemophilus influenzae in Brazil. Risk factors for being culture-negative, RT-PCR positive were determined. The sensitivity of
RT-PCR in cerebrospinal fluid (CSF) was 100% (95% confidence limits, 96.0%–100%) for N. meningitidis, 97.8% (85.5%–99.9%)
for S. pneumoniae, and 66.7% (9.4%–99.2%) for H. influenzae. Specificity ranged from 98.9% to 100%. Addition of RT-PCR to
routine microbiologic methods increased the yield for detection of S. pneumoniae, N. meningitidis, and H. influenzae cases by
52%, 85%, and 20%, respectively. The main risk factor for being culture negative and RT-PCR positive was presence of
antibiotic in CSF (odds ratio 12.2, 95% CI 5.9-25.0). RT-PCR using CSF was highly sensitive and specific and substantially
added to measures of meningitis disease burden when incorporated into routine public health surveillance in Brazil.
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Introduction
Bacterial meningitis is a serious and often fatal infection.
Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus
influenzae type b (Hib) account for the vast majority of bacterial
meningitis cases outside the neonatal period. Understanding
the burden of bacterial meningitis is important because of
recent advances in vaccines for these infections. Hib conjugate
vaccines have led to the near disappearance of invasive Hib
disease in Brazil and elsewhere [1]. Pneumococcal conjugate
vaccine has had a huge impact on the incidence of invasive
pneumococcal disease in the United States and is being
incorporated into the routine pediatric immunization schedule
in Brazil, as is serogroup C meningococcal conjugate vaccine
[2,3].
In many developing countries, surveillance for bacterial
meningitis is hampered by limited use of bacterial culture and
a high frequency of negative cultures [4]. Availability of over-
the-counter antibiotics, administration of antibiotics before
performance of lumbar puncture, lack of microbiology resources
for bacterial culture, and variable quality of microbiology
services are among the reasons for culture negativity. This
problem leads to an underestimate of disease burden and
assessments of the potential impact of vaccination. Non-culture
methods, such as real-time (RT)-PCR, can increase the
diagnostic yield for bacterial meningitis in both developed and
developing countries [4,5,6,7,8,9,10].
Much of what is known about the incidence of bacterial
meningitis in Brazil is from the Brazilian Reportable Diseases
Surveillance System (Sistema de Informac¸a˜o de Agravos de
Notificac¸a˜o [SINAN]), which conducts public health surveillance
for notifiable diseases. An annual average of 28,000 cases of
bacterial meningitis is reported nationwide, which likely underes-
timates disease burden because SINAN is a passive system. About
half of reported pyogenic meningitis cases are culture negative,
suggesting that use of RT-PCR could enhance measurement of
disease burden. The purpose of this study was to validate RT-PCR
when incorporated into routine public health surveillance and
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identify factors associated with being culture negative, RT-PCR
positive in Sa˜o Paulo.
Methods
Institutional review board (IRB) approvals
The study was approved by the Instituto Adolfo Lutz (IAL) and
University of Pittsburgh IRBs, as well as the Comissa˜o Nacional de
E´tica em Pesquisa, the Brazilian national IRB.
Data sources
We included nine hospitals in the city of Sa˜o Paulo (Instituto de
Infectologia Emı´lio Ribas, Casa de Sau´de Santa Marcelina,
Hospital Estadual do Grajau´, Hospital da Santa Casa de
Miserico´rdia de Sa˜o Paulo, Hospital Municipal Infantil Menino
Jesus, Hospital Sa˜o Paulo, Hospital Estadual Regional Sul,
Conjunto Hospitalar do Mandaqui, and Hospital Municipal do
Tatuape´) and three in nearby Campinas (Hospital das Clı´nicas-
Unicamp, Hospital Mario Gatti, and Hospital Celso Pierro),
selected because they are centers for treatment of bacterial
meningitis, report through SINAN, and send specimens for
performance of counter immunoelectrophoresis for N. meningitidis
and Hib at IAL, a Sa˜o Paulo State reference laboratory, or to IAL
Regional Laboratory of Campinas. IAL serves as the Brazilian
National Reference Laboratory for Bacterial Meningitis. Eleven of
the 12 hospitals conduct active surveillance for meningitis.
SINAN was queried for patients from these facilities for May 4,
2007 through March 31, 2009. Two non-mutually-exclusive
groups of patients were included: those with blood or cerebrospi-
nal fluid (CSF) culture positive for one of the three study organisms
and patients whose CSF had $100 leukocytes/mm3 and $60%
neutrophils, regardless of culture results. Patients in the culture
positive group were used in the analyses of the sensitivity of RT-
PCR, regardless of whether they met the CSF criteria. Patients
who were culture negative but met the CSF criteria were used to
determine the additional yield of RT-PCR. Other patients with
suspected meningitis who did not meet these criteria but who had
CSF submitted to IAL were used for the survival analyses
described in the data analysis section.
Information gathered from SINAN included results of blood and
CSF culture, demographic variables, and clinical and laboratory
variables. Medical record reviews were conducted to collect
information that was missing from SINAN. CSF and serum
specimens were sent to IAL for RT-PCR testing.
Culture results were obtained from SINAN, which were
confirmed during site visits to each of the hospital laboratories.
Some isolates were also sent to IAL for confirmation; those results
were added to the database if missing from SINAN.
Laboratory assays
A multiplex RT-PCR assay was used to identify patients with
bacterial meningitis caused by the three study organisms. The
assay was developed and performed at IAL and composed of
three sets of primers and a probe targeting 1), meningococcal
capsular transport gene ctrA [11], 2) pneumococcal autolysin gene
lytA [12], and 3) H. influenzae polysaccharide capsular expression
gene bexA, which detects H. influenzae serotypes a, b, c, and d, but
not e and f. [4].
The laboratory sensitivity of the assay was assessed with 55
isolates of N. meningitidis, 54 H. influenzae, and 66 S. pneumoniae. For
laboratory specificity, 125 bacterial and fungal isolates representing
other species were used to validate the three individual RT-PCR
assays (ctrA, lytA and bexA), and also the multiplex RT-PCR assay:
Acinetobacter baumannii, Cryptococcus sp, Coccidioides immitis, Chlamydia
pneumoniae, Chlamydia trachomatis, Corynebacterium ulcerans, Corynebacte-
rium diphtheria, Haemophilus parainfluenzae, Haemophilus influenzae
biogroup aegyptius, Enterobacter cloaceae, Enterococcus faecalis, Histoplas-
ma capsulatum, Klebsiella pneumoniae, Legionella sp, Leptospira interrogans,
Moraxella catarrhalis, Moraxella genitalium, Mycobacterium tuberculosis,
Nocardia asteroides, Pseudomonas aeruginosa, Paracoccidioides brasiliensis,
Pneumocystis carinii, Streptococcus agalactiae, Streptococcus mitis, Streptococcus
pyogenes, Neisseria lactamica, Neisseria sicca, Neisseria subflava, Salmonella sp,
Streptococcus viridians, and Listeria monocytogenes.
The lower limit of detection (LLD) was determined using
extracted DNA from one isolate each of N. meningitidis, H. influenzae
and S. pneumoniae. DNA concentration was adjusted to 100 ng/mL
from which 10 fold serial dilutions (1021 to 1029) were made in
PCR-grade water. The LLD for the individual and multiplex assays
were determined to be the dilution that yielded a Ct value #39.
DNA extraction was performed using QIAGEN QIAamp DNA
Blood mini kit (QIAGEN, Valencia, CA) as described by the
manufacturer except that ideally an aliquot of 500 mL of CSF or
200 mL of serum was processed and the DNA was eluted in 50 mL
or 100 mL of TE buffer, respectively. However, specimens with
smaller available volumes, representing around 40% of specimens,
were also included. 200 mL of PCR-grade water was included as
an extraction-negative control.
RT-PCR reactions were prepared in a separate area in which
no DNA or bacteria were handled and in a biosafety cabinet
cleaned with 1% sodium hypochlorite and exposed to UV light
for at least 20 minutes. Final reactions were prepared in 96 well
plates that included three separate positive controls, one for each
of the target organisms: strain N.24/75 serogroup A N.
meningitidis, strain ST.782/06 serotype 3 S. pneumoniae, and
H.18/06 Hib. These controls were prepared in 0.01 M PBS
pH 7.2 with 0.02% sodium azide, heated to 56uC for 30 minutes,
and maintained at 220uC. The extracted water and four
reactions without any DNA template were also included in each
plate as negative controls.
The assays were carried out in a final 25 ml reaction volume and
were performed using TaqMan Universal Master Mix (Applied
Biosystems, Foster City, CA), with 5 ml of sample extracted DNA.
Forward primer, reverse primer, and probe for each gene target
were used in concentrations of, respectively, 300, 900, and
100 nM for ctrA; 300, 600, and 100 nM for lytA; and 300, 300, and
100 nM for bexA. The ctrA, lytA, and bexA probes were labeled at
the 59 end with FAM, VIC, and NED, respectively.
All reactions were run in duplicate and the assays were
performed using an Applied Biosystems 7300 Real-Time PCR
System (Applied Biosystems) using the following cycling param-
eters: 50uC for 2 min, 95uC for 10 min, followed by 45 cycles of
95uC for 15 s and 60uC for 1 min. Extension of 55uC for 1 min
was used for single RT-PCR genogrouping assay for serogroups B,
W135, and Y. A positive result was defined as a cycle threshold
(Ct) value below 39, an inconclusive result as a Ct value of 40 or
41, and a negative result as a Ct value of zero or .41. All
inconclusive results and inconsistent replicates were repeated.
Other than Ct values, the positive reactions were confirmed for
each probe by the increase in fluorescence during the RT-PCR
reaction. To determine the influence of RT-PCR Ct cut-off value
on assay sensitivity, analysis using Ct values #35 as a second
definition for positivity was used for all culture positive samples.
For further evaluation of culture-negative, RT-PCR-positive
specimens, confirmation using a second gene was performed using
RT-PCR assays targeting group-specific genes of N. meningitidis
[11], ply from S. pneumoniae [4], or type-specific genes for H.
influenzae [13]. The meningococcal group-specific assay was also
used to determine meningococcal group.
RT-PCR for Bacterial Meningitis in Brazil
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CSF specimens with sufficient volume were tested for the
presence of antibiotic [6,14]. A 5 mm blank filter paper disc was
soaked with 15 mL of CSF and placed on Mueller Hinton agar
plate with a lawn of the pansensitive bacterium Kocuria rhizophila
(ATCC 9341). The plate was incubated overnight at 37uC and
zone of inhibition around the disc was measured at 24 hours. Any
zone was considered positive for presence of antibiotic. A disc
containing 0.015 U of penicillin was used as a positive control and
a blank disk was used as a negative control.
Data analysis
The sensitivity of RT-PCR for each pathogen was calculated as
the proportion of culture (blood and/or CSF) positive specimens
that had a positive result by RT- PCR for the same pathogen.
Specificity was calculated using two approaches. In the first, as the
proportion of all patients who were culture positive for one of the
other two pathogens that were RT-PCR negative for the pathogen
in question (specificity method 1). Patients who were culture positive
for organisms other than N. meningitidis, S. pneumoniae or H. influenzae
(e.g., Escherichia coli) were excluded. The presumption was that
specimens that are, for example, culture positive for N. meningitidis or
S. pneumoniae should be negative by RT-PCR for H. influenzae. In the
second, culture-negative specimens that met the CSF criteria of
$100 leukocytes/mm3 and $60% neutrophils were also included
(specificity method 2, unadjusted. To determine whether RT-PCR
positive, culture-negative specimens represented true RT-PCR
positives (because of false negative culture results), these specimens
were tested by PCR for a second gene target as indicated above.
Specimens that were positive for the second target were interpreted
as being true positives and therefore removed from the specificity
calculation (specificity method 2, adjusted).
For the analyses of percent of patients with positive RT-PCR
assay by CSF WBC count and CSF percent neutrophils, patients
who were culture negative and who met the CSF criteria were
included. CSF specimens that were culture negative or culture
unknown that were submitted for routine testing for suspected
bacterial meningitis, regardless of CSF profile, were also included.
Survival analyses were performed to determine the proportion of
RT-PCR positive samples that would be detected and the
proportion of samples that would be tested at any specific WBC
value.
To investigate factors associated with being culture-negative,
cases were defined as patients who met the CSF criteria above and
were culture negative and RT-PCR positive. Controls were
patients who had positive CSF and/or blood cultures. Univariate
logistic regression was done in SAS (version 9.2, SAS Institute) to
identify risk factors. Transformations were performed on contin-
uous factors that were not approximately linear to facilitate
inclusion in the model. Factors with a p-value ,0.1 were eligible
for inclusion in multivariable logistic regression analysis. A
backward logistic regression model with a stay criterion of 0.05
was run to identify independent risk factors for being culture
negative. Factors remaining in the final model were checked for
colinearity.
Results
Laboratory validation of RT-PCR assay
All N. meningitidis, H. influenzae and S. pneumoniae used in the
evaluation of sensitivity of the RT-PCR assays were positive in the
species-specific assay targeting the ctrA, bexA and lytA genes,
respectively (laboratory sensitivity of 100%). DNA from strains
representing other species gave negative results in all assays
(laboratory specificity of 100%). The LLD for the individual and
multiplex RT-PCR assays was 20 fg of genomic DNA.
Validation of RT-PCR assay on clinical specimens
There were 162 patients who were culture positive for one of
the three target organisms and 460 who met the CSF criteria
(Table 1). Of the 460 patients, 123 were culture positive for one of
the three target organisms and 337 were culture negative. The
median age was 9 years, 60.9% were male, and 9.6% were
recorded as having died. Around a third of patients had the
presence of antibiotic in CSF. Among 11 of the hospitals, the
proportion of patients with presence of antibiotic in CSF ranged
from 0.0% to 50.0% and in the one remaining hospital, a large
referral facility, the proportion was 88.1%. For some analyses
(Figures 1, 2, 3), an additional 188 specimens from patients with
unknown culture results were included. Among 428 CSF speci-
mens, 173, 70, and 3 were RT-PCR positive for N. meningitidis, S.
pneumoniae, or H. influenzae, respectively. For 232 serum specimens
tested, 48, 17, and 0 were RT-PCR positive for the same
organisms, respectively.
The sensitivity of RT-PCR in CSF for diagnosis of meningitis
was 100% (95% confidence limits, 96.0%–100%) for N. meningitidis,
97.8% (88.5%–99.9%) for S. pneumoniae, and 66.7% (9.4%–99.2%)
for H. influenzae (Table 2). Specificity for the three organisms
ranged from 98.9% to 100% (specific methods 1 and 2, adjusted),
with narrow confidence limits. Positive and negative predictive
values (PPV and NPV, respectively) of RT-PCR in CSF ranged
from 98.3%–100% and 98.9%–100%, respectively (data not
shown). For RT-PCR in serum, the sensitivities were lower and
specificities were 94.1%–100% (Table 2).
Molecular genogrouping of N. meningitidis in CSF
Among 90 meningococcal culture-positive patients, the sero-
group distribution as determined by molecular genogrouping was
10 (11.1%) group B, 67 (74.4%) group C, 11 (12.2%) group W-
135, 1 (1.1%) group Y, and 1 (1.1%) non-groupable. For 83
culture negative, RT-PCR positive cases, the distribution was 10
(12.0%) group B, 64 (77.1%) group C, 4 (4.8) group W-135, 1
group Y (1.2%), and 4 (4.8%) non-groupable.
Table 1. Characteristics of patients included in the study.
Characteristic No. (%) (n =499)*
Male gender 301 (60.9%)
Age (median, range) 9 (0–82)
Deceased 40 (9.6%)
Culture-positive
N. meningitidis 107 (21.4%)
S. pneumoniae 50 (10.0%)
H. influenzae 5 (1.0%)
CSF $100 WBCs and $60% PMNs 460 (93.7%)
Culture positive, 1 of 3 target organisms 123
Culture negative 337
Positive CSF antibiotic assay 142 (34.6%)
Of the 499 patients, 263 had CSF sample only, 67 had serum sample only, and
169 had both CSF and serum samples.
*Denominators for some characteristics ,499 because of missing data for some
patients
SF, cerebrospinal fluid; WBCs, white blood cells; PMNs, polymorphonuclear cells.
doi:10.1371/journal.pone.0020675.t001
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Increased yield of RT-PCR over and above culture-based
results
A total of 26 culture-negative, RT-PCR-positive patients with
pneumococcal meningitis were identified, for additional yield of
52.0% of RT-PCR over the 50 culture-based results; of the 26, 23
were identified by testing CSF only, 2 by both CSF and serum, and
1 by serum only. For N. meningitidis, there were 91 culture negative
patients with positive RT-PCR results for an additional yield of RT-
PCR over the 107 culture-positive patients, an 85.0% increased
yield; of the 91, 67 were identified by testing CSF only, 13 by both
CSF and serum and 11 by serum only. The increased yield was 20%
for H. influenzae, with 5 culture positive cases and 1 additional RT-
PCR, culture negative case, which was identified by testing CSF.
Relationship between CSF characteristics and RT-PCR
positivity
Among culture-negative and culture-unknown specimens, there
was a strong relationship between the WBC and percent
neutrophils in CSF and the percent of CSFs that were RT-PCR
positive (Figures 1 and 2). For example, 4.9% of CSF specimens
with 0–499 WBCs were positive, as compared to 73.2% for CSFs
with at least 2,000 WBCs (Figure 1). Similarly, the proportion of
specimens that were RT-PCR positive increased with increasing
CSF percent neutrophils (Figure 2).
An analysis of all culture negative and culture unknown CSF
specimens that were tested was conducted to determine optimal CSF
cut-offs (Figure 3). For example, if we had used a cut-off of at least
Figure 2. Proportion of culture-negative and culture-unknown 452 CSF specimens that were RT-PCR positive, by cerebrospinal
fluid (CSF) percent neutrophils. Numbers above bars represent the number of specimens tested. Includes 188 patients with unknown culture
results.
doi:10.1371/journal.pone.0020675.g002
Figure 1. Proportion of culture-negative and culture-unknown 481 CSF specimens that were RT-PCR positive, by cerebrospinal
fluid (CSF) white blood cell (WBC) count (leukocytes/mm3). Numbers above bars represent the number of specimens tested. Includes 188
patients with unknown culture results.
doi:10.1371/journal.pone.0020675.g001
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500 CSF leukocytes/mm3 to determine which specimens should
undergo RT-PCR testing, we would have tested only 44% of sub-
mitted specimens yet identified 95% of specimens that were RT-PCR
positive. Alternatively, a cut-off of at least 1,000 CSF leukocytes/
mm3would have required the testing of only 34% of specimens,
which would have resulted in detection of 92% of positives.
Risk factors for being culture negative and RT-PCR
positive
In univariate analysis of risk factors for being a culture negative,
RT-PCR positive case (n = 118), using culture positive patients as
controls (n = 162), presence of antibiotic in CSF (odds ratio 15.5,
95% CL 8.3-29.1, p,0.0001), age$18 (OR 2.3, 95% CL 1.4, 3.7,
p,0.0012), higher CSF WBC (median 4,400 among cases, 1,280
among controls, p,0.0001), and being from one of three hospitals
(hospital numbers 3, 6, or 11) (OR 6.8, 95% CL 4.0-11.6) were all
associated with being a case (Table 3).
In multivariable analysis, being from one of the three hospitals,
presence of antibiotic in CSF, age $18, and infection with N.
meningitidis were independent risk factors (Table 4). Hospitals 3, 6,
and 11 had the highest proportion of cases with antibiotic in CSF
(35.7%, 41.7%, and 88.1%, respectively).
Discussion
We found that RT-PCR, when incorporated into routine public
health surveillance performed well and added substantially to
estimates of public health burden for N. meningitidis and S.
pneumoniae. This indicates that RT-PCR could be used as an
Figure 3. Relationship between minimum CSF WBC count used as a cut-off to determine what specimens are tested by RT-PCR and
1) the proportion of the total RT-PCR positives (n=122) that are identified (dashed line) and 2) the proportion of all specimens
(n=481) that would be tested (solid line). For example, if only those specimens with a CSF WBC of at least 1000 had been tested, about 34% of
the 481 CSF specimens would have been tested, which would have detected about 92% of the 122 specimens that were RT-PCR positive. Data were
censored at a CSF WBC cut-off of 10,000. Data are for culture-negative and culture unknown specimens. Includes 188 patients with unknown culture
results.
doi:10.1371/journal.pone.0020675.g003
Table 2. Determination of sensitivity and specificity of RT-PCR assay for N. meningitidis (ctrA), S. pneumoniae (lytA), and
H. influenzae (bexA) in cerebrospinal fluid and serum specimens (see text for details).
Pathogen No.* Sensitivity 95% CIs
Specificity-
Method 1** No.* 95% CIs
Specificity-Method
2, unadjusted*** No. 95% CIs
Specificity-Method
2, adjusted**** No.* 95% CIs
CEREBROSPINAL FLUID
N. meningitidis 90 100% 96.0–100 100% 51 93.0–100 75.7% 342 70.8–80.2 98.9% 262 96.7–99.8
S. pneumoniae 46 97.8% 88.5–99.9 100% 94 96.2–100 93.5% 386 90.6–95.8 100% 361 99.0–100
H. influenzae 3 66.7% 9.4–99.2 100% 139 97.4–100 99.8% 433 98.7–100 100% 432 99.2–100
SERUM
N. meningitidis 21 57.1% 34.0–78.2 100% 12 73.5–100 83.1% 223 77.4–87.9 94.1% 188 89.8–97.0
S. pneumoniae 10 80.0% 44.4–97.5 100% 25 86.3–100 96.2% 235 92.9–98.2 100% 226 98.4–100
H. influenzae 2 0% 0–84.2 100% 33 89.4–100 100% 243 98.5–100 100% 243 98.5–100
*Number of specimens contributing to the calculation of sensitivity or specificity
**Specificity determined using specimens positive for other organisms
***Specificity determined using specimens positive for other organisms or culture negative
****Specificity determined using specimens positive for other organisms or culture negative but positive for second gene target.
doi:10.1371/journal.pone.0020675.t002
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adjunct for surveillance for bacterial meningitis in developing
countries. Although Brazil is a middle-income country, RT-PCR
has been demonstrated to be useful in all types of settings, from
low income to highly developed countries [4,6,7]. RT-PCR has
the added advantage of providing results more rapidly than culture
and has also been shown to be an excellent tool for epidemics [15].
We performed RT-PCR in a public health reference laboratory to
increase the sensitivity of bacterial meningitis surveillance, not for
clinical diagnosis. However, when used in the clinical setting,
timeliness is a major advantage of RT-PCR because it can
generally be completed on the same day as opposed to bacterial
culture, which generally requires 2–3 days.
The RT-PCR assay we used had a high sensitivity and
specificity in CSF when compared to bacterial culture. A high
sensitivity (around 90%) has been previously described for RT-
PCR in CSF for N. meningitidis and S. pneumoniae [4]. We found
that the RT-PCR assay we used, although quite specific, was not
as sensitive in serum, which is in line with a recent systematic
review and meta-analysis [16]. Serum is known to contain PCR
inhibitors and the DNA polymerase we used is sensitive to
inhibition [17,18]. In addition, collection of blood in ethylene-
diaminetetraacetic acid (EDTA) is generally preferred over serum
for PCR because of EDTA inhibition of DNA degradation.
Despite the relative lack of sensitivity, RT-PCR in serum still
managed to detect a substantial number of culture-negative cases.
However, given the high sensitivity of the assay in CSF and the
modest increased yield from testing serum alone, one could argue
that serum should be tested only if a CSF specimen were not
available.
Lack of specificity of PCR for detection of S. pneumoniae in
serum using ply as the gene target in children with high rates of
pneumococcal carriage has been reported [19]. However, the
specificity of the pneumococcal component of our assay in serum
was very high, despite inclusion of sera from 31 children ,2 years
old (data not shown) in the specificity calculation; this may be due
to the higher specificity of lytA as a primary gene target as
Table 3. Univariate analysis of risk factors for being a RT-PCR positive, culture-negative case-patient, using culture positive
patients as controls.
Risk Factor Cases, No. (%) Controls, No. (%) OR 95% CI p-value
Male gender 69 (58.5%) 102 (63.4%) 0.8 0.5-1.3 0.41
Age $18 years 59 (50.0%) 49 (30.6%) 2.3 1.4–3.7 0.0012
Hospitalized 113 (99.1%) 160 (99.4%) 0.7 0.04–11.4 0.81
Race - White 61 (67.8%) 66 (55.9%) Baseline 0.22
White vs. Black 4 (4.4%) 7 (5.9%) 0.6 0.2–2.2
White vs. Brown 25 (27.8%) 45 (38.1%) 0.6 0.3–1.1
Antibiotic in CSF 79 (76.7%) 25 (17.5%) 15.5 8.3–29.1 ,0.0001
CSF MIC (mm) 21.0 (7–53) 21.0 (9–40) 0.59
CSF glucose 16 (0–101) 10 (0–610) 0.06
CSF WBC count (cell/mm3) 4,400 (100–29600) 1,280 (1–95200) ,0.0001
CSF % neutrophils 89 (60–99) 86 (0–100) 0.11
CSF protein (xx) 286.5 (22–4854) 230 (11–2789) 0.14
Hospital
Hospital 10 1 (0.9%) 22 (13.6%) Baseline ,0.0001
Hospital 1 vs. 10 10 (8.5%) 22 (13.6%) 10.0 1.2–84.9
Hospital 2 vs. 10 8 (6.8%) 21 (13.0%) 8.4 0.96–72.9
Hospital 3 vs. 10 19 (16.1%) 26 (16.1%) 16.1 2.0–129.9
Hospital 4 vs. 10 1 (0.9%) 2 (1.2%) 11.0 0.5–250.9
Hospital 5 vs. 10 5 (4.2%) 22 (13.6%) 5.0 0.5–46.4
Hospital 6 vs. 10 8 (6.8%) 4 (2.5%) 44.0 4.3–454.9
Hospital 7 vs. 10 2 (1.7%) 5 (3.1%) 8.8 0.7–117.2
Hospital 8 vs. 10 2 (1.7%) 14 (8.6%) 3.1 0.3–38.0
Hospital 9 vs. 10 4 (3.4%) 9 (5.6%) 9.8 0.96–99.9
Hospital 11 vs. 10 57 (48.3%) 13 (8.0%) 96.5 11.9–781.9
Hospital 12 vs. 10 1 (0.9%) 2 (1.2%) 11.0 0.5–250.9
Hospital 3, 6, 11 vs. others 84 (71.2%) 43 (26.5%) 6.8 4.0–11.6 ,0.0001
Bacterial species
N. meningitidis 91 (77.1%) 108 (66.7%) 1.7 0.98–2.9 0.06
S. pneumoniae 26 (22.0%) 50 (30.9%) 0.6 0.4–1.1 0.10
H. influenzae 1 (0.9%) 5 (3.1%) 0.3 0.03–2.3 0.23
There were a total of 118 case-patients and 162 controls. For some calculations, denominators differ because of missing data for some patients.
OR, odds ratio; CI, confidence interval; CSF, cerebrospinal fluid; MIC, minimum inhibitory concentration of CSF against strain of Kocuria rhizophila among specimens with
detectable antibiotic; WBC, white blood cell.
doi:10.1371/journal.pone.0020675.t003
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compared to ply [20]. The small number of H. influenzae cases was
due to the decline in Hib disease following incorporation of Hib
conjugate vaccines into the routine pediatric immunization
schedule in Brazil, which limited our ability at assess performance
of the H influenzae component of our assay.
This study points out the difficulty in evaluating a diagnostic test
that performs better than the ‘‘gold standard’’, bacterial culture in
this case, to which it is compared. Culture of normally sterile body
fluids is generally considered to be very specific but can suffer from
lack of sensitivity, particularly in the presence of antibiotics. This
phenomenon can make the diagnostic test appear to be less
specific than it truly is when culture negative specimens (some of
which may have the presence of the organism despite the negative
culture) are included. We attempted to circumvent this problem by
measuring specificity first by using only specimens that were
culture positive for another pathogen and second after correcting
for what appeared to be false positive RT-PCR results by testing
these ‘‘false positives’’ using a second gene target. In this study, the
calculated specificities were very high using both approaches,
which makes us confident that we have accurately assessed the true
specificity of the assay.
The results of this study suggest that surveillance programs that
use RT-PCR for diagnosis of bacterial meningitis can establish
WBC count cut-offs that optimize both detection of cases and
utilization of laboratory resources. For example, a large number of
samples could be excluded without missing a substantial proportion
of bacterial meningitis cases using WBC count cut-offs of, for
example, 500 or 1000. Programs with patient characteristics that
differ from those in our study should consider similar analyses to
determine the optimal cut-offs for their setting.
We were able to determine the meningococcal group among
culture-negative cases using a PCR-based assay; a similar
approach is available for H. influenzae (10, 12). We are also
exploring non-culture approaches for determining pneumococcal
serotype [21]. These serotype and serogroup data are important
for monitoring the impact of the conjugate vaccines that are
currently being used in Brazil.
We found that the most important risk factor for being culture
negative/RT-PCR positive was presence of antibiotic in CSF,
which has been previously described [6]. This finding is not
surprising because antibiotics are widely available over-the-
counter in Brazil [22]. In addition, it is likely that some patients
were given antibiotics by healthcare workers before CSF and/or
blood were obtained for culture. We suspect that the finding that
being from one of three hospitals was a risk factor for being culture
negative, RT-PCR positive was due to residual confounding
because these hospitals had the highest rates of CSF specimens
with the presence of antibiotic. However, other hospital-specific
factors cannot be excluded, such as how specimens were collected,
stored, and prepared for submission at the hospitals. The finding
that infection with N. meningitidis is a risk factor for being culture-
negative, RT-PCR positive may reflect the fact that this organism
tends to be sensitive to most antibiotics, whereas drug resistance is
common among S. pneumoniae isolates submitted to IAL [23,24].
Why age $18 years was a risk factor is unclear but residual
confounding may be a factor.
Public health surveillance in Brazil has been changed
substantially as a result of this study. RT-PCR is now performed
routinely on all serum and CSF specimens from patients with
suspected bacterial meningitis submitted to IAL. In addition, IAL
is acquiring two additional RT-PCR systems for its regional
laboratories to expand availability of the assay in Sa˜o Paulo
State. Furthermore, the Brazilian Ministry of Health is asking all
state reference laboratories to introduce RT-PCR into their
routine.
In conclusion, RT-PCR for diagnosis of bacterial meningitis was
successfully incorporated into public health surveillance for
bacterial meningitis in Sa˜o Paulo. Future studies will involve use
of novel molecular approaches that could supplant our current
assay and provide diagnosis for a broader array of pathogens
[25,26]. Despite success of this program in increasing the
proportion of laboratory diagnosed bacterial meningitis cases, we
still have a substantial number of pyogenic meningitis cases
without an etiologic diagnosis. Given the public health impact and
potential vaccine preventability of this disease, further investiga-
tion is needed.
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